文献速递甲状腺疾病垂体与肾上腺疾病

中枢性先天性甲状腺功能减退症的认识:一项多中心回顾性分析

Insights Into Central Congenital Hypothyroidism: A Multicenter Retrospective Analysis.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

该研究在以色列9个儿科内分泌单位回顾性分析1987-2021年诊断的94例中枢性先天性甲状腺功能减退症(CCH)患者,患病率约1:42800活产儿,84%合并多种垂体激素缺乏,新生儿筛查仅检出3例,早期与晚期诊断组神经发育结局无显著差异。

要点

  • CCH患病率约1:42800活产儿,84%合并多种垂体激素缺乏,16%为孤立性CCH。
  • 新生儿筛查仅检出3例,66%因生长和发育迟缓较晚诊断。
  • 神经发育后遗症包括精神发育迟滞12%、学习困难18%、言语延迟27%、运动笨拙19%,早期与晚期诊断组无显著差异。

核心结论

  • 尽管神经发育后遗症发生率高,但早期与晚期诊断组之间未发现差异。
  • 需要进一步研究评估延迟诊断对CCH新生儿神经发育结局的影响,并改进新生儿CCH检测策略。

研究设计与样本

  • 多中心横断面回顾性病历审查,覆盖以色列9个儿科内分泌单位。
  • 纳入1987-2021年诊断的CCH患者94例(54例男性),分为早期诊断组(生后14天内)和晚期诊断组(14天后)。
  • 新生儿筛查结果从国家新生儿筛查项目数据集回顾性获取。

主要发现

  • 以色列CCH患病率约1:42800活产儿。
  • 94例患者中84%合并多种垂体激素缺乏,16%为孤立性CCH。
  • 诊断中位年龄50天(范围1-8760天),66%为中度至重度甲状腺功能减退。
  • 新生儿筛查仅检出3例婴儿。
  • 早期诊断占34%(因垂体功能减退),66%因生长和发育迟缓较晚诊断。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究评估延迟诊断对CCH新生儿神经发育结局的影响。
  • 需要改进新生儿CCH检测策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Central congenital hypothyroidism (CCH) is a thyroid hormone deficiency at birth caused by inadequate pituitary stimulation of the thyroid gland. Although primary congenital hypothyroidism has been studied extensively, studies on CCH are sparse. OBJECTIVE: To assess the prevalence of CCH in Israel and describe its clinical features, neonatal screening results, and outcomes. METHODS: This multicenter cross-sectional retrospective chart review covered 9 pediatric endocrine units throughout Israel; patients diagnosed with CCH in 1987-2021 were categorized into early (within 14 days of life) and late (after 14 days) diagnosis groups. Newborn screening (NBS) results were retrospectively retrieved from the national NBS program dataset. RESULTS: CCH prevalence in Israel was about 1:42 800 live births. Subjects were 94 patients (54 males), of these, 84% had multiple pituitary hormone deficiencies and 16% had isolated CCH. The median age at diagnosis was 50 days (range, 1-8760), with 66% having moderate to severe hypothyroidism. NBS detected only 3 infants. Early diagnosis occurred in 34% due to hypopituitarism, while 66% were diagnosed later due to growth and developmental delays. Neurodevelopmental sequelae included mental retardation (12%), learning difficulties (18%), delayed speech (27%), and motor clumsiness (19%), with no significant differences in outcomes between early and late diagnosis. CONCLUSION: Despite high rates of neurodevelopmental sequelae, no differences were found between early and late diagnosis groups. Further research is needed to assess the impact of delayed diagnosis on neurological outcomes in newborns with CCH. Improved strategies for detecting CCH in newborns are also necessary.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. German A, Almashanu S, de Vries L, et al. Insights Into Central Congenital Hypothyroidism: A Multicenter Retrospective Analysis. J Clin Endocrinol Metab. 2025. PMID: 39008607. doi:10.1210/clinem/dgae485

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。